Articles with public access mandates - Anna RosatiLearn more
Not available anywhere: 1
Efficacy and safety of ketamine in refractory status epilepticus in children
A Rosati, M L’Erario, L Ilvento, C Cecchi, T Pisano, L Mirabile, R Guerrini
Neurology 79 (24), 2355-2358, 2012
Mandates: Fondazione Telethon, Italy
Available somewhere: 13
Experimental designs for small randomised clinical trials: an algorithm for choice
C Cornu, B Kassai, R Fisch, C Chiron, C Alberti, R Guerrini, A Rosati, ...
Orphanet journal of rare diseases 8, 1-12, 2013
Mandates: National Institute of Health and Medical Research, France, UK Medical …
HCN1 mutation spectrum: from neonatal epileptic encephalopathy to benign generalized epilepsy and beyond
C Marini, A Porro, A Rastetter, C Dalle, I Rivolta, D Bauer, R Oegema, ...
Brain 141 (11), 3160-3178, 2018
Mandates: National Institute of Health and Medical Research, France, Wellcome Trust …
Diagnostic implications of genetic copy number variation in epilepsy plus
A Coppola, E Cellini, H Stamberger, E Saarentaus, V Cetica, D Lal, ...
Epilepsia 60 (4), 689-706, 2019
Mandates: US National Science Foundation, Swiss National Science Foundation, US …
A randomized phase III trial of adjunctive zonisamide in pediatric patients with partial epilepsy
R Guerrini, A Rosati, J Segieth, S Pellacani, K Bradshaw, L Giorgi
Epilepsia 54 (8), 1473-1480, 2013
Mandates: Fondazione Telethon, Italy, Government of Italy
Real-life survey of pitfalls and successes of precision medicine in genetic epilepsies
S Balestrini, D Chiarello, M Gogou, K Silvennoinen, C Puvirajasinghe, ...
Journal of Neurology, Neurosurgery & Psychiatry 92 (10), 1044-1052, 2021
Mandates: National Institute for Health Research, UK, Wellcome Trust, Government of Italy
Adjunctive zonisamide therapy in the long‐term treatment of children with partial epilepsy: Results of an open‐label extension study of a phase III, randomized, double‐blind …
R Guerrini, A Rosati, K Bradshaw, L Giorgi
Epilepsia 55 (4), 568-578, 2014
Mandates: Fondazione Telethon, Italy, European Commission, Government of Italy
Congenital disorders of glycosylation presenting as epileptic encephalopathy with migrating partial seizures in infancy
C Barba, F Darra, R Cusmai, E Procopio, C Dionisi Vici, L Keldermans, ...
Developmental Medicine & Child Neurology 58 (10), 1085-1091, 2016
Mandates: Netherlands Organisation for Scientific Research
Is Focal Cortical Dysplasia/Epilepsy Caused by Somatic MTOR Mutations Always a Unilateral Disorder?
R Guerrini, M Cavallin, T Pippucci, A Rosati, F Bisulli, P Dimartino, ...
Neurology: Genetics 7 (1), e540, 2020
Mandates: Government of Italy
Results from an Italian expanded access program on cannabidiol treatment in highly refractory Dravet syndrome and Lennox–Gastaut syndrome
LF Iannone, G Arena, D Battaglia, F Bisulli, P Bonanni, A Boni, ...
Frontiers in neurology 12, 673135, 2021
Mandates: Government of Italy
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial
N Staplin, R Haynes, PK Judge, C Wanner, JB Green, J Emberson, ...
The Lancet Diabetes & Endocrinology 12 (1), 39-50, 2024
Mandates: British Heart Foundation, UK Medical Research Council, National Institute …
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial
PK Judge, N Staplin, KJ Mayne, C Wanner, JB Green, SJ Hauske, ...
The Lancet Diabetes & Endocrinology 12 (1), 51-60, 2024
Mandates: British Heart Foundation, UK Medical Research Council, National Institute …
Phenotypic spectrum of seizure disorders in MBD5-associated neurodevelopmental disorder
KA Myers, C Marini, GL Carvill, A McTague, J Panetta, C Stutterd, ...
Neurology: Genetics 7 (2), e579, 2021
Mandates: US National Institutes of Health, National Health and Medical Research …
An Italian consensus on the management of Lennox-Gastaut syndrome
A Riva, A Coppola, C Di Bonaventura, M Elia, E Ferlazzo, G Gobbi, ...
Seizure 101, 134-140, 2022
Mandates: Government of Italy
Publication and funding information is determined automatically by a computer program